About Intusomics

Science-first.
Deeply personal.

We are a Contract Research Organization (CRO) specialized in bioinformatics. We don't provide a service — we conduct your research. Every project is a scientific investigation that belongs to you, executed with full rigor, personalized methodology, and deep biological interpretation.

Our Mission

What drives us

Intusomics Analytics was built to address a recurring issue in omics projects: data generation at scale is often paired with analysis that prioritizes speed and standardization over study-specific biology. One-size-fits-all settings can miss subtle signals — especially when a project requires batch-effect correction, clinical-study-aware endpoints, or updated methods tailored to its design.

As a CRO, we don't process your data — we investigate it. Each engagement is a contracted research project with a defined scientific question, a custom methodology, and a commitment to genuine discovery. We design the full analytical strategy around your experimental setup, sample type, and biological question. We deliver results you can publish, patent, and act on.

Genuine Discovery

We prioritize real biological insight over computational throughput. Every result is scrutinized for biological plausibility, not just statistical thresholds.

Personalized Partnership

We work alongside your team as a contracted research partner, not a service provider. You sponsor the research; we execute it with full scientific rigor from study design through final deliverables.

Proprietary Innovation

We develop and deploy our own Deep Learning algorithms and proprietary methodologies, consistently exceeding what off-the-shelf tools can achieve.

100%
Custom workflows, no generic pipelines
1-on-1
Direct expert access on every project
Deep L.
Proprietary AI models for single-cell
IP
Full pathway from data to patent
Leadership

Meet the Founder

Daniel Arenas
Founder & CEO

Daniel Arenas

Daniel Arenas González is the Founder and Scientific Director of Intusomics Analytics. He trained at the Universidad de Alcalá, where he built a broad foundation across the key areas of human health sciences. He then went on to develop a research career in Regenerative Medicine at the Instituto de Investigación Hospital Universitario 12 de Octubre (imas12), contributing to the development of mesenchymal stem cell therapies for multiple sclerosis and urinary incontinence under GMP conditions.

His profile combines wet-lab expertise with advanced computational analysis — designing and implementing omics data pipelines including bulk and single-cell RNA-seq, metagenomics and differential expression, working on high-performance computing clusters using R, Python, Nextflow and containerized environments. He previously collaborated as a bioinformatician with the Molecular Immunonutrition group at IMDEA Alimentación through a VIU–IMDEA research collaboration, applying transcriptomic analysis to precision nutrition intervention studies.

Principles

How we work

01

Tailored from day one

We begin every project with a deep consultation to understand your biology, your data, and your goals. No assumptions, no templates.

02

Transparency in methodology

Every analytical decision is documented and justified. We provide full, publication-ready methods sections so your work is reproducible and defensible.

03

Confidentiality as default

Your data, findings, and intellectual property are protected throughout the entire collaboration — before, during, and after delivery.

04

Results that go beyond the screen

We don't stop at the analysis. We support you in publishing, patenting, and translating your findings into tangible scientific and commercial value.

Scientific Advisory Board

Our advisors

Our Scientific Advisory Board brings together leading researchers across genomics, computational biology, clinical research, and translational medicine, ensuring that our methodologies remain at the cutting edge of the field.

Dr. Ana Isabel Flores de la Cal
Dr. Ana Isabel Flores de la Cal
Regenerative Medicine
Instituto de Investigación Hospital 12 de Octubre (i+12) · Spain
Board actively expanding New international advisors joining across genomics, clinical research and translational medicine.

Ready to work together?

Tell us about your project. We'll respond within 24–48 hours.

Get in touch →